0000000000390979

AUTHOR

Paul-georg Knapstein

showing 5 related works from this author

Surgical therapy of recurrent vulvar cancer.

2005

Objective The success of various surgical interventions in 201 cases with recurrent vulvar carcinoma was examined in the light of patients' pretreatment, surgical therapy, plastic reconstruction, and postoperative disease course. Study design A databank of standardized clinical data was analyzed using statistical procedures. Results Therapy was selected on an individual basis according to tumor status. Recurrence at a site distant from the primary tumor, particularly in the inguinal region, indicated a markedly unfavorable prognosis. In contrast, tumors recurring locally did not exhibit any significant differences. Plastic surgery reconstruction led to improvements with respect to operabili…

Adultmedicine.medical_specialtyReconstructive surgeryDatabases FactualVulvaTumor StatusGynecologic Surgical ProceduresmedicineHumansVulvar DiseasesAgedRecurrent Vulvar CarcinomaVulvar neoplasmAged 80 and overWound HealingVulvar Neoplasmsbusiness.industryCarcinomaObstetrics and GynecologyMiddle AgedPlastic Surgery Proceduresmedicine.diseasePrognosisPrimary tumorSurvival AnalysisSurgeryPlastic surgerymedicine.anatomical_structureFemaleNeoplasm Recurrence LocalbusinessAmerican journal of obstetrics and gynecology
researchProduct

Immunohistochemical Detection of Hormone Receptors in Breast Carcinomas (ER-ICA, PgR-ICA): Prognostic Usefulness and Comparison with the Biochemical …

1994

In a prospective study conducted since 1983, the hormone-receptor status of primary breast carcinomas was investigated using immunohistochemical (ER-ICA, PgR-ICA) and biochemical (DCC) methods. The degree of immunohistochemical staining was evaluated according to the immunoreactive score (IRS) devised by Remmele and Stegner [Frauenarzt 28, 41-43 (1987)]. The findings obtained using the biochemical radioactive-ligand-binding assay (cutoff level, 20 fmol/mg) and those obtained using qualitative immunohistochemical methods were in agreement in 72.5% (ER-ICA) and 72.2% (PgR-ICA) of cases. For the 789 cases of primary breast carcinoma examined, postoperative data were available for a mean follow…

Pathologymedicine.medical_specialtyMammary glandBreast NeoplasmsRadioligand AssayPredictive Value of TestsCarcinomaHumansMedicineProspective StudiesSurvival analysisProportional Hazards ModelsEpitheliomabusiness.industryObstetrics and GynecologyPrognosismedicine.diseaseSurvival Analysismedicine.anatomical_structureReceptors EstrogenOncologyHormone receptorPredictive value of testsImmunohistochemistryFemaleReceptors ProgesteronebusinessBreast carcinomaGynecologic Oncology
researchProduct

Intraarterielle präoperative Chemotherapie fortgeschrittener Zervixkarzinome

1991

Three patients suffering from very advanced primary cancers of the cervix uteri (FIGO II B or III B) were treated. By preoperative selective perfusion of both uterine arteries, using cis-platinum alone, a distinct reduction of the tumour volume was achieved. This was demonstrated clinically and also by CAT scan and NMR technique. The elevated serum CEA and SCC levels decreased to normal values. The histomorphology of the Wertheim-Meigs specimens revealed no tumour invasion of the initially infiltrated parametria. This treatment modality has been developed to minimise the toxic side effects of the inductive (neo-adjuvant) chemotherapy for cervical cancers.

medicine.medical_specialtyChemotherapyPathologybusiness.industrymedicine.medical_treatmentObstetrics and GynecologyCancerNormal valuesmedicine.diseaseElevated serummedicine.anatomical_structureMaternity and MidwiferymedicineIntra arterialPreoperative chemotherapyRadiologybusinessPerfusionCervixGeburtshilfe und Frauenheilkunde
researchProduct

Reconstructive plastic surgery in the treatment of vulvar carcinomas

2005

Abstract Objective The results obtained using plastic surgery reconstruction in 207 patients with a primary or recurrent vulvar carcinoma were analyzed with regard to the surgical procedures applied, pre-treatment and post-operative findings, along with the long-term oncological disease course. Study design Standardized data concerning the surgical procedures applied and clinical factors were collected in a databank and statistically analyzed. Results The flaps employed were termed either ‘local' (cutaneous or fasciocutaneous; n =84) or ‘regional' (myocutaneous, n =123). For local flaps, the rate of secondary healing was 31%, dropping to 20% for regional flaps. Such healing disturbances oft…

Adultmedicine.medical_specialtyThighSurgical FlapsDisease courseGynecologic Surgical ProceduresmedicineHumansSecondary healingAgedAged 80 and overRecurrent Vulvar CarcinomaWound HealingVulvar Neoplasmsbusiness.industryAdvanced stageObstetrics and GynecologyMiddle AgedPlastic Surgery Proceduresmedicine.diseaseSurvival AnalysisSurgeryPlastic surgeryStenosisTreatment Outcomemedicine.anatomical_structureReproductive MedicineFemaleVulvar CarcinomaNeoplasm Recurrence LocalbusinessEuropean Journal of Obstetrics & Gynecology and Reproductive Biology
researchProduct

C-erbB-2-oncogene expression in breast carcinoma: Analysis by S1 nuclease protection assay and immunohistochemistry in relation to clinical parameters

1992

The c-erbB-2 mRNA was detected by the S1 nuclease protection assay and Northern blotting in breast cancer tissues. In contrast to the Northern blot analysis which has been used in all recent publications concerning c-erbB-2 expression on the level of RNA, the S1-nuclease protection assay has distinct advantages with respect to sensitivity, reproducibility, and handling of radioactive probes. We compared the expression of c-erbB-2 in 120 breast carcinomas which were operated in the years 1989-1990 on the level of the mRNA (S1 nuclease protection assay) and the protein (immunohistochemistry), respectively. In general, results obtained with both methods were in good agreement. Only minor diffe…

Pathologymedicine.medical_specialtyReceptor ErbB-2Breast NeoplasmsBiologyGene Expression Regulation EnzymologicImmunoenzyme TechniquesBreast cancerProto-Oncogene ProteinsGene expressionmedicineHumansRNA NeoplasmNorthern blotskin and connective tissue diseasesLymph nodeOncogeneSingle-Strand Specific DNA and RNA EndonucleasesObstetrics and GynecologyBlotting Northernmedicine.diseaseSurvival AnalysisGene Expression Regulation NeoplasticBlotmedicine.anatomical_structureOncologyCancer researchImmunohistochemistryFemaleBreast carcinomaGynecologic Oncology
researchProduct